A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

NCT01006057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: insulin degludec
DRUG: insulin degludec
DRUG: insulin degludec
DRUG: insulin degludec
DRUG: insulin degludec

Sponsor

Novo Nordisk A/S